Gene · 4211
MEIS1: Meis homeobox 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MEIS1: Meis homeobox 1. Genes, record 4211. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4211
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O00470 | Homeobox protein Meis1 | 390 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents49
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 52994 | O00470 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2815 | O00470 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2381 | O00470 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 8520 | O00470 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15279 | O00470 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7003 | O00470 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7003 | O00470 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2381 | O00470 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2815 | O00470 | Espacenet |
| JP 2025032187 A | 2025-03-11 | 20 | O00470 | Espacenet |
1 to 10 of 49
See all 49 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,432
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MEIS1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 43 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 22 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 19 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 14 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 10 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 9 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 9 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 8 | 2025 |
| ZIASC010378 | Activation of Proto-Oncogenes by Chromosomal Translocation | 8 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 7 | 2025 |
1 to 10 of 2,432Source NIH's project files
See all 2,432 nih grantsPapers2,719
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human-biased MEIS1 expression by a promoter noncoding RNA regulates neural stem cell proliferation. | Life Sci Alliance | 2026 | 42816420 | PubTator, text mining | PubMed |
| Menin inhibitors in acute myeloid leukaemia: Mechanisms, clinical pharmacology, and emerging therapeutic strategies. | Crit Rev Oncol Hematol | 2026 | 42805358 | PubTator, text mining | PubMed |
| Genome-wide association study of restless legs syndrome in end-stage renal disease. | Sleep Adv | 2026 | 42765040 | PubTator, text mining | PubMed |
| Candidate MicroRNA Regulatory Axes in Melanoma CD8+ T Cell Exhaustion: A Network-Based In Silico Stratification. | Cureus | 2026 | 42763729 | PubTator, text mining | PubMed |
| Paedomorphic Patterns of Gene Expression in the Eyes of Brook Salamanders. | Integr Comp Biol | 2026 | 42747168 | PubTator, text mining | PubMed |
| Targeting the Menin-KMT2A Axis in AML: Translating Molecular Insights into Therapeutic Success. | Clin Lymphoma Myeloma Leuk | 2026 | 42637611 | PubTator, text mining | PubMed |
| Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines. | Int J Mol Sci | 2026 | 42589252 | PubTator, text mining | PubMed |
| Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output. | Cold Spring Harb Perspect Biol | 2026 | 42575696 | PubTator, text mining | PubMed |
| Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold. | Int J Hematol | 2026 | 42565971 | PubTator, text mining | PubMed |
| [MLL-rearranged leukemia and menin inhibitors]. | Rinsho Ketsueki | 2026 | 42543643 | PubTator, text mining | PubMed |
1 to 10 of 2,719
See all 2,719 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4211
GET https://conductscience.org/api/genes/v1/4211/patents?page=2